Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TSX/CTX stock hub

TSX/CTX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSX/CTXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

14.1M

Toronto Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSX/CTX

In the news

Latest news · TSX/CTX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-0.6

P25 -121.5P50 -40.9P75 0.5

ROIC-13

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSX/CTX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

186

Groups with data

Currency

CAD

Showing 186 of 186 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees Change	0%
Employees Change Percent	0
Enterprise value	CAD 5.9M
Exchange	Toronto Stock Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA2258471028
Last refreshed	2026-05-10
Market cap	CAD 14.1M
Price	CAD 0.76
Price currency	CAD
Sector	Healthcare
Sic	2834
Symbol	tsx/CTX
Website	https://www.crescitatherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.65%
EV Earnings	-64.14x
EV/EBITDA	13.14x
EV/FCF	-168.59x
EV/Sales	0.28x
FCF yield	-0.25%
P/B ratio	0.91x
P/S ratio	0.67x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-4.84%
EBITDA Margin	0.21%
Gross margin	52.6%
Gross Profit	CAD 11.1M
Gross Profit Growth	23.57%
Gross Profit Growth Q	12.83%
Gross Profit Growth3 Y	-5.54%
Gross Profit Growth5 Y	-0.29%
Net Income	CAD -92,000
Net Income Growth Years	1%
Pretax Margin	-0.39%
Profit Margin	-0.44%
ROA	-3.03
Roa5y	-3.7
ROCE	-6.55
ROE	-0.59
Roe5y	-5.51
ROIC	-12.97
Roic5y	-15.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-7.06%
Cagr1y	31.06%
Cagr3y	4.29%
Cagr5y	-1.02%
EPS Growth Years	1
FCF Growth Q	-64.32%
OCF Growth	-60.62%
OCF Growth Q	-69.77%
OCF Growth5 Y	-28.16%
Revenue Growth	7.86x
Revenue Growth Q	-13.72x
Revenue Growth Years	2x
Revenue Growth3 Y	-3.53x
Revenue Growth5 Y	6.19x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 1
Assets	CAD 20.3M
Cash	CAD 8.6M
Current Assets	CAD 15.7M
Current Liabilities	CAD 4.7M
Debt	CAD 334,000
Debt EBITDA	CAD 0.7
Debt Equity	CAD 0.02
Debt FCF	CAD -9.54
Equity	CAD 15.6M
Interest Coverage	-24.33
Liabilities	CAD 4.8M
Long Term Assets	CAD 4.6M
Long Term Liabilities	CAD 33,000
Net Cash	CAD 8.2M
Net Cash By Market Cap	CAD 58.29
Net Cash Growth	-2.32%
Net Debt EBITDA	CAD -187
Net Debt Equity	CAD -0.53
Tangible Book Value	CAD 14.1M
Tangible Book Value Per Share	CAD 0.76
WACC	3.6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.33
Inventory Turnover	2.28
Net Working Capital	CAD 2.8M
Quick ratio	2.27
Working Capital	CAD 11M
Working Capital Turnover	CAD 2.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.61%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-51.9%
1Y total return	31.03%
200-day SMA	0.53
3Y total return	13.43%
50-day SMA	0.66
50-day SMA vs 200-day SMA	50over200
5Y total return	-5%
All Time High	1.99
All Time High Change	-61.81%
All Time High Date	2016-09-08
All Time Low	0.35
All Time Low Change	117.14%
All Time Low Date	2018-04-30
ATR	0.01
Beta	-0.15
Beta1y	-2.31
Beta2y	-0.76
Ch YTD	58.33
High	0.76
High52	0.76
High52 Date	2026-05-07
High52ch	0%
Low	0.76
Low52	0.4
Low52 Date	2025-11-25
Low52ch	90%
Ma50ch	15.29%
Price vs 200-day SMA	43.13%
RSI	77.44
RSI Monthly	67.05
RSI Weekly	78.73
Sharpe ratio	0.72x
Sortino ratio	1.63
Total Return	2.61%
Tr YTD	58.33
Tr1m	2.7%
Tr3m	52%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -1M
Operating margin	-4.84

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	16,105,218%
Net Borrowing	-515,000
Shares Insiders	13.48%
Shares Out	18,613,938
Shares Qo Q	-1.25%
Shares Yo Y	-2.61%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -106,000
Average Volume	13,161.95x
Bv Per Share	0.84
CAPEX	CAD -1.1M
Ch10y	-51.9
Ch1m	2.7
Ch1y	31.03
Ch3m	52
Ch3y	13.43
Ch5y	-5
Ch6m	58.33
Change	0%
Change From Open	0
Close	0.76
Days Gap	0
Depreciation Amortization	1,066,000
Dollar Volume	19
Earnings Date	2026-05-15
EBIT	CAD -1M
EBITDA	CAD 44,000
EPS	CAD -0
F Score	5
FCF	CAD -35,000
FCF EV Yield	-0.59x
FCF Per Share	CAD -0
Financing CF	-788,000
Fiscal Year End	December
Founded	2,016
Income Tax	CAD 9,000
Investing CF	-973,000
Is Primary Listing	1
Last Earnings Date	2025-11-07
Last Report Date	2025-12-31
Ma150	0.53
Ma150ch	42.64%
Ma20	0.75
Ma20ch	1.2%
Net CF	-696,000
Next Earnings Date	2026-05-15
Open	0.76
P OCF Ratio	13.18
Ppne	1,787,000
Price Date	2026-05-07
Price EBITDA	CAD 322
Ptbv Ratio	1
Relative Volume	0x
Revenue	21,118,000x
SBC By Revenue	0.34x
Share Based Comp	71,000
Tax By Revenue	0.04x
Tr6m	58.33%
Volume	25
Z Score	-0.39

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSX/CTX pay a dividend?

Capital-return profile for this ticker.

Performance

TSX/CTX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSX/CTX?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+13.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-2.6%

Negative means the company is buying back shares.

Technical

TSX/CTX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

77.4

Above 70: short-term overbought

Price vs 200-day MA

+43.1%

50/200-day relationship not available

Beta (5Y)

-0.15

Less volatile than the market

Sharpe ratio

0.72

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSX/CTX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsx/CTX stock rating?

tsx/CTX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsx/CTX analysis?

The full report lives at /stocks/tsx/CTX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsx/CTX?

The latest report frames tsx/CTX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsx/CTX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.